NALT,
does it really help with Greater absorption than ordinary L-tyrosine, leading to improved focus and cognition under stress?
research showsNo controlled human efficacy trial was located in which oral NALT itself was tested for improving focus or cognition under stress, so the grade is ?. The claim that it is better absorbed than ordinary L-tyrosine also lacks a direct oral human comparison, while intravenous nutrition studies suggest that NALT is poorly used as a tyrosine source. Plasma tyrosine did not rise after NALT infusion in healthy people or hemodialysis patients, and healthy participants excreted 60% of the dose in urine; another adult nutrition study found about 35% excreted unchanged. Evidence about ordinary L-tyrosine under stress cannot simply be transferred to chemically distinct NALT. Thyroid disease, thyroid hormone, and monoamine oxidase inhibitor use are addressed separately under safety.
ads claimFormulation terms such as acetylated, water-soluble, and high absorption are joined directly to human focus benefits. Dissolving readily in a product, being converted into usable tyrosine, and improving a cognitive task under stress are three separate claims that require separate testing.
Useful facts when choosing a product
- NALT is an acetyl derivative of L-tyrosine and is more water-soluble, but that physical property does not establish superior oral absorption or bioavailability in humans.
- Commercial supplements vary in NALT content and other ingredients, and no clinically established NALT dose exists for improving focus under stress.
- Doses and effects from ordinary L-tyrosine studies should not be converted one-for-one to the NALT label amount. The compounds differ in molecular weight, hydrolysis, and metabolic utilization.
- People with hyperthyroidism or those using thyroid hormone, levodopa, or a monoamine oxidase inhibitor should review possible interactions with a clinician. Evidence for long-term high-dose use during pregnancy or breastfeeding is also inadequate.
What the research actually shows
Druml and colleagues in 1991 compared intravenous N-acetyltyrosine and tyrosine dipeptides in seven healthy people and eight hemodialysis patients. Plasma tyrosine did not increase after NALT in either group, and healthy participants excreted 60% of infused NALT in urine. Hoffer and colleagues in 2003 found that about 35% of NALT was excreted unchanged in 13 adults receiving parenteral nutrition. A 2015 review by Attipoe and colleagues made a weak favorable recommendation for cognition under stress from studies of ordinary L-tyrosine, not from evidence establishing NALT efficacy. No direct oral human absorption comparison between NALT and L-tyrosine and no randomized NALT focus or cognition trial were located through the search date.
Why this is classified as ?
Human NALT literature is confined largely to parenteral metabolism studies, with no oral randomized trial of focus or cognition under stress. Intravenous data showing no plasma tyrosine increase and substantial unchanged urinary excretion do not support superior utilization marketing. Under the no-human-efficacy-literature rule, the grade is ? with a null score; the weak ordinary L-tyrosine signal is separate.
Counterpoint. Ordinary L-tyrosine has shown signals on selected cognitive tasks during acute cold, sleep deprivation, noise, or other stressors. Anyone considering that possibility should distinguish the ingredient form and direct clinical evidence instead of assuming NALT is equivalent.
Rejudgment record. New verdict — Assigned ? because no human efficacy trial of NALT for focus or cognition under stress was located; parenteral pharmacokinetic evidence of poor tyrosine conversion and unchanged excretion argues against the superior-absorption subclaim, while ordinary L-tyrosine evidence was not attributed to NALT
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Improved focus and cognition under stress from NALT | ? | No human efficacy trial evaluating oral NALT itself was located. |
| Greater absorption and utilization than ordinary L-tyrosine | D | No direct oral human comparison exists, and intravenous data showed no plasma tyrosine increase and 35% to 60% unchanged excretion. |
| Stress-cognition effects of ordinary L-tyrosine | C | Small human trials provide a weak positive signal across varied conditions and tasks, but this evidence is separate from NALT. |
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Druml W et al. 1991 | Comparative intravenous pharmacokinetic study in healthy and hemodialysis participants | 8 | Non-United States government research support; not a supplement marketing trial | NALT clearance, plasma tyrosine increase, and urinary excretion | Plasma tyrosine did not increase after NALT, and healthy participants excreted 60% of the infused dose in urine. | Human pharmacokinetics pointing against superior utilization |
| Hoffer LJ et al. 2003 | Adult parenteral-nutrition metabolism and retention study | 13 | Non-United States government research support; Abbott Aminosyn II was the nutrition product used | Unchanged urinary excretion and retention of NALT | Approximately 35% of administered NALT was excreted unchanged in urine. | Limited human evidence supporting low metabolic utilization |
| Attipoe S et al. 2015 | Rapid evidence assessment of ordinary L-tyrosine studies in healthy adults | 4 | United States military and academic research | Performance under physical and cognitive stress | A weak favorable recommendation was possible for ordinary L-tyrosine under cognitive stress, but NALT efficacy was not evaluated. | Evidence distinguishing a different ingredient form |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-07-20).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-20 · Corrections: none
Cite this verdict
[Chamgap] NALT x superior absorption and improved focus and cognition under stress — Evidence Grade ?. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/cognition/n-acetyl-l-tyrosine-absorption-stress-cognition/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.